GT
EW icon

Greenleaf Trust’s Edwards Lifesciences EW Stock Holding History

Greenleaf Trust’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.92M Buy
32,233
+32
+0.1% +$2.68K 0.03% 164
2026
Q1 		$2.58M Sell
32,201
-346
-1% -$28.5K 0.03% 169
2025
Q4 		$2.77M Sell
32,547
-81
-0.2% -$6.65K 0.03% 153
2025
Q3 		$2.54M Buy
32,628
+402
+1% +$31.4K 0.02% 167
2025
Q2 		$2.52M Sell
32,226
-663
-2% -$49.4K 0.02% 166
2025
Q1 		$2.38M Buy
32,889
+444
+1% +$31.8K 0.02% 179
2024
Q4 		$2.4M Sell
32,445
-71
-0.2% -$4.97K 0.02% 168
2024
Q3 		$2.15M Sell
32,516
-2,779
-8% -$202K 0.02% 187
2024
Q2 		$3.26M Sell
35,295
-799
-2% -$70.8K 0.03% 126
2024
Q1 		$3.45M Buy
36,094
+693
+2% +$58.2K 0.03% 121
2023
Q4 		$2.7M Sell
35,401
-1,030
-3% -$71.7K 0.03% 142
2023
Q3 		$2.52M Sell
36,431
-2,087
-5% -$168K 0.03% 134
2023
Q2 		$3.63M Buy
38,518
+14
+0% +$1.22K 0.04% 107
2023
Q1 		$3.19M Buy
38,504
+2,795
+8% +$220K 0.04% 120
2022
Q4 		$2.66M Sell
35,709
-3,081
-8% -$237K 0.03% 132
2022
Q3 		$3.21M Sell
38,790
-5,482
-12% -$527K 0.05% 107
2022
Q2 		$4.21M Sell
44,272
-7,341
-14% -$760K 0.06% 79
2022
Q1 		$6.08M Sell
51,613
-27,174
-34% -$3.05M 0.07% 60
2021
Q4 		$10.2M Sell
78,787
-110,584
-58% -$12.9M 0.12% 47
2021
Q3 		$21.4M Sell
189,371
-3,054
-2% -$349K 0.26% 23
2021
Q2 		$19.9M Sell
192,425
-865
-0.4% -$81.5K 0.25% 23
2021
Q1 		$16.2M Buy
193,290
+736
+0.4% +$62.2K 0.21% 30
2020
Q4 		$17.6M Buy
192,554
+8,864
+5% +$735K 0.23% 28
2020
Q3 		$14.7M Buy
183,690
+549
+0.3% +$42.8K 0.23% 31
2020
Q2 		$12.7M Buy
183,141
+4,908
+3% +$349K 0.22% 33
2020
Q1 		$11.2M Buy
178,233
+4,353
+3% +$314K 0.22% 26
2019
Q4 		$13.5M Sell
173,880
-4,479
-3% -$350K 0.21% 26
2019
Q3 		$13.1M Sell
178,359
-1,701
-0.9% -$119K 0.2% 24
2019
Q2 		$11.1M Sell
180,060
-387
-0.2% -$23.4K 0.18% 28
2019
Q1 		$11.5M Buy
180,447
+720
+0.4% +$41.1K 0.19% 24
2018
Q4 		$9.18M Sell
179,727
-2,709
-1% -$137K 0.18% 26
2018
Q3 		$10.6M Sell
182,436
-5,460
-3% -$267K 0.19% 25
2018
Q2 		$9.12M Sell
187,896
-975
-0.5% -$45.5K 0.17% 24
2018
Q1 		$8.78M Sell
188,871
-5,391
-3% -$234K 0.17% 26
2017
Q4 		$7.3M Buy
194,262
+3,330
+2% +$122K 0.15% 41
2017
Q3 		$6.96M Sell
190,932
-7,074
-4% -$270K 0.15% 41
2017
Q2 		$7.8M Sell
198,006
-17,430
-8% -$636K 0.18% 30
2017
Q1 		$6.75M Sell
215,436
-10,833
-5% -$339K 0.16% 37
2016
Q4 		$7.07M Buy
226,269
+1,935
+0.9% +$62.7K 0.19% 38
2016
Q3 		$9.02M Buy
224,334
+13,080
+6% +$493K 0.24% 29
2016
Q2 		$7.02M Sell
211,254
-22,041
-9% -$754K 0.18% 38
2016
Q1 		$6.86M Buy
+233,295
New +$6.44M 0.19% 43

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

Greenleaf Trust's EW Position: Q2 2026 in Review

Greenleaf Trust increased its Edwards Lifesciences (EW) stake by 0.1% in Q2 2026, buying an estimated $2.68K and bringing the position to 32,233 shares worth $2.92M. The position accounts for 0.03% of the portfolio, ranked #164.

Greenleaf Trust first reported a position in EW in Q1 2016 and has held it in 42 quarters since. The position peaked at $21.4M in Q3 2021. 505 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Greenleaf Trust held 32,233 shares of Edwards Lifesciences worth $2.92M as of Q2 2026.
  • Greenleaf Trust bought 32 Edwards Lifesciences shares in Q2 2026, an estimated $2.68K.
  • Edwards Lifesciences made up 0.03% of Greenleaf Trust's portfolio in Q2 2026, its #164 holding.
  • Greenleaf Trust first reported a position in Edwards Lifesciences in Q1 2016 and has held it in 42 quarters since.
  • Greenleaf Trust's Edwards Lifesciences position peaked at $21.4M in Q3 2021.
  • 505 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.